Sort by
Refine Your Search
-
46 000 students and 8 500 staff based in Lund, Helsingborg and Malmö. We are united in our efforts to understand, explain and improve our world and the human condition. Section of Oncology, RNA
-
university. More information about us, please visit: the Department of Biochemistry and Biophysics . Project description Project title: Perturbation-based Multi-omics Inference of Gene Regulatory Networks
-
collaborates with prominent universities from all around the world, which ensures opportunities for international exchanges. Ribocure Pharmaceuticals AB, based in Gothenburg, is a clinical‑stage biotech company
-
Transformer-Based Foundation Model for DNA Methylation in Longitudinal Cohorts.” The focus is on developing next-generation AI models for the analysis of DNA methylation. Using longitudinal data from, among
-
symptoms emerge. The group combines large population-based and twin cohorts with longitudinal blood-based biomarkers, multi-omics data, and advanced epidemiological methods. The group is part of the research
-
interdisciplinary collaboration. An interest in animals is a plus. About us The position is based at the Department of Animal Biosciences at SLU in Uppsala, within the Animal Locomotion and Emotion Laboratory
-
. The project is based on a close collaboration with researchers at the Department of Immunology, Genetics and Pathology (IGP) at Uppsala University and SciLifeLab . About the DDLS research program The PhD
-
. You would be welcomed in the the Yant Lab (https://www.yantlab.net/ ) Using large-scale graph-based pangenomics and forward evolutionary simulations, the student will develop predictive models
-
for therapy. To do this, we interrogate the spatial relationships between B and T cell clones and their immediate niches within tissues using our in-house developed spatial transcriptomics-based technology
-
, which is dedicated to the growing field of life sciences that investigates the molecular basis of disease and explores molecularly and genetically based treatments. There will be opportunities